Company intelligence / Profile preview

Amphora Medical

Minneapolis, Minnesota, United Statesdnb.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The Selective Bladder Denervation System demonstrated potential to restore normal bladder function and provide lasting symptom improvement in feasibility studies. Two ongoing feasibility studies were completed with plans to initiate a pivotal, randomized, sham-controlled clinical trial in women refractory to medical therapy for OAB. No public results from pivotal trials are available post-acquisition.

Therapeutic areas: Urology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Boston Scientific CorporationF-Prime Capital PartnersLongitude CapitalHBM Healthcare Investments

Beyond the preview

Go deeper on Amphora Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amphora Medical.

Explore the full profile